Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole stress ulcer prophylaxis in critically ill ICU adults
NL-OMON42819Phase 3Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in stress ulcer comparing Pantoprazole with Placebo (2 arms). Primary endpoint: Mortality at 90 days after randomization. Started Jul 2016; status: active, not recruiting.
02
Drugs
pantoprazole
03
Conditions
stress ulcer
Beyond the preview
Go deeper on NL-OMON42819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42819.